Company / Named in our posts
NRx Pharmaceuticals.
Follow NRx PharmaceuticalsNRx Pharmaceuticals is a clinical-stage biopharmaceutical company developing therapeutics for central nervous system disorders, specifically suicidal depression and post-traumatic stress disorder (PTSD).[1]
01Deal
Deals on Carrywatch
Every deal that names NRx Pharmaceuticals, and its role in each.
Relief / NRx Pharmaceuticals
Relief to receive NRx Pharmaceuticals aviptadil program assets
See deal detailsDeal Web
NRx Pharmaceuticals and 0 firms it shares a posted deal with, and the path to any other firm.
Financials
5 fiscal years of figures as NRx Pharmaceuticals reported them.
News
Loading headlines.
Sources
As of 24 Oct 2026.
- 01NRx Pharmaceuticals Reports Third Quarter 2022 Financial Results and Provides Business Update
U.S. Securities and Exchange Commission · Researched 24 Oct 2026
- 02Form 8-K, filed November 14, 2022
U.S. Securities and Exchange Commission · Researched 24 Oct 2026
Deal posts naming NRx Pharmaceuticals:
- P01